Investor · New York, NY

Edward Giordano

Open Edward in the network graph →

Filings

15

SEC Form D

Connections

62

co-filers

Capital

$405.2M

across filings

Active

Oct 2021

to Apr 2025

Most-connected co-filers (62)

Telmo Martins · Chicago, IL15 shared James R. Fellows · Chicago, IL10 shared Sabrina W. Rusnak-Carlson · Boston, MA10 shared Christopher J. Flynn · Boston, MA9 shared Martin Pawlik · New York, NY7 shared Oliver Bell · NEW YORK, NY7 shared Michael Cardamone · New York, NY7 shared William L. Chang · La Jolla, CA7 shared Jeffrey B. Miller · New Athens, IL7 shared Joshua M. Hile · Issaquah, WA7 shared Curtis L. Rosebraugh · La Jolla, CA7 shared Thomas Chladek · Baar, V87 shared Jared Kleinert · NEW YORK, NY7 shared David L. Humphrey · La Jolla, CA7 shared Adam L. Levin · La Jolla, CA7 shared Andrew L. Benton · La Jolla, CA7 shared Philip R. Cater · GEORGE TOWN, GRAND CAYMAN, Cayman Islands7 shared Steve L. Martin · La Jolla, CA7 shared Admire Chatiza · London, United Kingdom7 shared Bob L. Gower · La Jolla, CA7 shared D L. Kirkpatrick · La Jolla, CA7 shared John A. Levin · New York, NY6 shared Benjamin M. Lyons · Raleigh, NC6 shared Lee L. Rauch · La Jolla, CA6 shared

Recent filings (15)

Ensysce Biosciences, Inc.Apr 2025 · 25 co-filers$2.2M Ensysce Biosciences, Inc.Apr 2025 · 25 co-filers$1.1M FEPCF Founders Fund, L.P.Mar 2025 · 27 co-filers Ensysce Biosciences, Inc.Sep 2024 · 25 co-filers$5.1M Park Square Capital European Loan Partners II, SCSpApr 2024 · 10 co-filers FEPCF Founders Fund, L.P.Mar 2024 · 31 co-filers Ensysce Biosciences, Inc.Feb 2024 · 25 co-filers$4.7M FEPCF Founders Fund, L.P.Jun 2023 · 31 co-filers Ensysce Biosciences, Inc.Mar 2023 · 25 co-filers$2.8M Park Square Capital Credit Opportunities IV (USD), SCSpOct 2022 · 10 co-filers PSC Credit Opportunities IV (USD) Feeder, SCSpOct 2022 · 10 co-filers Ensysce Biosciences, Inc.Jul 2022 · 25 co-filers$8.5M PSC Credit Opportunities IV (USD) Feeder, SCSpOct 2021 · 10 co-filers Park Square Capital Credit Opportunities IV (USD), SCSpOct 2021 · 10 co-filers Ensysce Biosciences, Inc.Oct 2021 · 22 co-filers$15.9M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Edward in the interactive graph →